DEBBANE RAYMOND Insider Trades

Insider Trading History

Track insider trading activity for DEBBANE RAYMOND. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Lexicon Pharmaceuticals
Lexicon Pharmaceuticals LXRX
Director
Holding Value $0 0 shares
Last Trade
Jun 03, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$165k 89,312 shares
$1.85
$2.12
Lexicon Pharmaceuticals
Lexicon Pharmaceuticals LXRX
Director
Holding Value $4.23M 1,995,498 shares
Last Trade
Jun 03, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$165k 89,312 shares
$1.85
$2.12
Lexicon Pharmaceuticals
Lexicon Pharmaceuticals LXRX
Director
Holding Value $75.7k 35,714 shares
Last Trade
May 01, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$58.2k 35,714 shares
$1.63
$2.12
Lexicon Pharmaceuticals
Lexicon Pharmaceuticals LXRX
Director
Holding Value $92.2k 43,478 shares
Last Trade
May 01, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$70k 43,478 shares
$1.61
$2.12
Lexicon Pharmaceuticals
Lexicon Pharmaceuticals LXRX
Director
Holding Value $4.04M 1,906,186 shares
Last Trade
Feb 25, 2026 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$2.98k 2,000 shares
$1.49
$2.12
Lexicon Pharmaceuticals
Lexicon Pharmaceuticals LXRX
Director
Holding Value $4.04M 1,904,186 shares
Last Trade
Feb 23, 2026 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$147k 100,000 shares
$1.47
$2.12
Lexicon Pharmaceuticals
Lexicon Pharmaceuticals LXRX
Director
Holding Value $3.82M 1,804,186 shares
Last Trade
Feb 20, 2026 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$148k 100,000 shares
$1.48
$2.12
Lexicon Pharmaceuticals
Lexicon Pharmaceuticals LXRX
Director
Holding Value $3.61M 1,704,186 shares
Last Trade
Feb 19, 2026 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$72k 50,000 shares
$1.44
$2.12
Lexicon Pharmaceuticals
Lexicon Pharmaceuticals LXRX
Director
Holding Value $3.51M 1,654,186 shares
Last Trade
Feb 18, 2026 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$176k 133,688 shares
$1.32
$2.12
Lexicon Pharmaceuticals
Lexicon Pharmaceuticals LXRX
Director
Holding Value $3.22M 1,520,498 shares
Last Trade
Feb 17, 2026 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$101k 76,857 shares
$1.31
$2.12
Lexicon Pharmaceuticals
Lexicon Pharmaceuticals LXRX
Director
Holding Value $3.06M 1,443,641 shares
Last Trade
Feb 13, 2026 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$75.9k 57,952 shares
$1.31
$2.12
Lexicon Pharmaceuticals
Lexicon Pharmaceuticals LXRX
Director
Holding Value $220k 103,806 shares
Last Trade
Jun 03, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$64.4k 103,806 shares
$0.62
$2.12
Lexicon Pharmaceuticals
Lexicon Pharmaceuticals LXRX
Director
Holding Value $0 0 shares
Last Trade
May 13, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$23.2k 36,810 shares
$0.63
$2.12
Lexicon Pharmaceuticals
Lexicon Pharmaceuticals LXRX
Director
Holding Value $2.94M 1,385,689 shares
Last Trade
May 13, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$23.2k 36,810 shares
$0.63
$2.12
Lexicon Pharmaceuticals
Lexicon Pharmaceuticals LXRX
Director
Holding Value $95.2k 44,906 shares
Last Trade
May 13, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$80.4k 44,906 shares
$1.79
$2.12
Lexicon Pharmaceuticals
Lexicon Pharmaceuticals LXRX
Director
Holding Value $0 0 shares
Last Trade
Apr 28, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$12.7k 8,032 shares
$1.58
$2.12
Lexicon Pharmaceuticals
Lexicon Pharmaceuticals LXRX
Director
Holding Value $2.86M 1,348,879 shares
Last Trade
Apr 28, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$12.7k 8,032 shares
$1.58
$2.12
Lexicon Pharmaceuticals
Lexicon Pharmaceuticals LXRX
Director
Holding Value $2.84M 1,340,847 shares
Last Trade
Oct 12, 2023 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$153k 148,820 shares
$1.03
$2.12
Lexicon Pharmaceuticals
Lexicon Pharmaceuticals LXRX
Director
Holding Value $2.53M 1,192,027 shares
Last Trade
Oct 11, 2023 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$370k 342,874 shares
$1.08
$2.12
Lexicon Pharmaceuticals
Lexicon Pharmaceuticals LXRX
Director
Holding Value $1.8M 849,153 shares
Last Trade
Oct 10, 2023 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$579k 508,306 shares
$1.14
$2.12

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up